In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Arkansas basketball has a 91.6% success rate on challenges this season. Meet the man in charge of guiding John Calipari's decision-making.